About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Tg(Lck*F505)3073Rmp
transgene insertion 3073, Roger M Perlmutter
MGI:3032775
Summary 3 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
cx1
Ptprctm1Holm/Ptprctm1Holm
Tg(Lck*F505)3073Rmp/?
involves: 129/Sv * C57BL/6 * DBA/2 MGI:3032910
cx2
Lattm4.1Mal/Lattm4.1Mal
Tg(Lck*F505)3073Rmp/?
involves: 129P2/OlaHsd * C57BL/6 * DBA/2 MGI:4357976
tg3
Tg(Lck*F505)3073Rmp/? involves: C57BL/6J * DBA/2 MGI:3032815


Genotype
MGI:3032910
cx1
Allelic
Composition
Ptprctm1Holm/Ptprctm1Holm
Tg(Lck*F505)3073Rmp/?
Genetic
Background
involves: 129/Sv * C57BL/6 * DBA/2
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ptprctm1Holm mutation (11 available); any Ptprc mutation (188 available)
Tg(Lck*F505)3073Rmp mutation (0 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
neoplasm
• aggressive thymic tumors in 100% of mice
• earliest morbidity at 10 weeks and median survival was to 12 weeks

immune system
• thymus glands with tumours also have 5X normal cell numbers

hematopoietic system
• thymus glands with tumours also have 5X normal cell numbers

endocrine/exocrine glands
• thymus glands with tumours also have 5X normal cell numbers
• aggressive thymic tumors in 100% of mice
• earliest morbidity at 10 weeks and median survival was to 12 weeks




Genotype
MGI:4357976
cx2
Allelic
Composition
Lattm4.1Mal/Lattm4.1Mal
Tg(Lck*F505)3073Rmp/?
Genetic
Background
involves: 129P2/OlaHsd * C57BL/6 * DBA/2
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Lattm4.1Mal mutation (0 available); any Lat mutation (9 available)
Tg(Lck*F505)3073Rmp mutation (0 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
immune system
• spleen cellularity is increased 3-fold compared to transgenics on a wild-type background
• CD4+CD5+ T cell numbers are increased over 5-fold compared to controls
• serum IgE levels are about 10,000-fold higher than controls
• serum IgG1 levels are more than 100-fold higher than controls
• transgene allows rescue of deficient thymocyte development of Lat-null mice
• 60% of these T cells express IL-4 upon PMA stimulation
• Th2 T cells hyper proliferate and stimulate immunoglobulin production
• 60% of peripheral T cells express IL-4 upon PMA stimulation

hematopoietic system
• spleen cellularity is increased 3-fold compared to transgenics on a wild-type background
• CD4+CD5+ T cell numbers are increased over 5-fold compared to controls
• serum IgE levels are about 10,000-fold higher than controls
• serum IgG1 levels are more than 100-fold higher than controls
• transgene allows rescue of deficient thymocyte development of Lat-null mice
• 60% of these T cells express IL-4 upon PMA stimulation
• Th2 T cells hyper proliferate and stimulate immunoglobulin production

growth/size/body
• spleen cellularity is increased 3-fold compared to transgenics on a wild-type background




Genotype
MGI:3032815
tg3
Allelic
Composition
Tg(Lck*F505)3073Rmp/?
Genetic
Background
involves: C57BL/6J * DBA/2
Find Mice Using the International Mouse Strain Resource (IMSR)
No mouse lines available in IMSR.
See publication links below for author information.
phenotype observed in females
phenotype observed in males
N normal phenotype
neoplasm
N
• unlike mice carrying transgenes of this gene which express greater than 20 pg of mRNA per ug of total RNA, no thymic tumors develop during the first year of life





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
05/07/2024
MGI 6.23
The Jackson Laboratory